Sex differences in kappa opioid receptor function and their potential impact on addiction

Frontiers in Neuroscience

Volumn 9, Issue DEC, 2015, Pages

  Chartoff, Elena H ^a   Mavrikaki, Maria ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Analgesia; Antinociception; Depression; Dopamine; Drug withdrawal; Estrogens; Female

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; COCAINE; CYCLAZOCINE; DYNORPHIN; ESTROGEN; GONADORELIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; LUTEINIZING HORMONE; MELANOCORTIN 1 RECEPTOR; MU OPIATE RECEPTOR; N (TETRAHYDROFURFURYL)NORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALBUPHINE; NALTREXONE; OPIATE; PENTAZOCINE; PRODYNORPHIN; SALVINORIN A; SAMIDORPHAN; SEX HORMONE; SPIRADOLINE; TESTOSTERONE;

AFFECT; ANALGESIA; ANXIETY; COCAINE DEPENDENCE; DEPRESSION; DIMERIZATION; DRUG DEPENDENCE; DRUG SEEKING BEHAVIOR; DYSPHORIA; FEMALE; GENE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HORMONE ACTION; HUMAN; MAJOR DEPRESSION; MALE; MANIA; NEUROANATOMY; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; PAIN; PAIN THRESHOLD; PDYN GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOSIS; QUANTITATIVE TRAIT LOCUS MAPPING; REVIEW; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; WITHDRAWAL SYNDROME;

EID: 84954532615     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00466     Document Type: Review

References (215)

1. Abraham, K. E., Brewer, K. L., and McGinty, J. F. (2000). Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury. Neuroscience 99, 189-197. doi: 10.1016/S0306-4522(00)00150-0.
2. Al-Hasani, R., and Bruchas, M. R. (2011). Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115, 1363-1381. doi: 10.1097/aln.0b013e318238bba6.
3. Arvidsson, U., Riedl, M., Chakrabarti, S., Vulchanova, L., Lee, J. H., Nakano, A. H., et al. (1995). The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl. Acad. Sci. U.S.A. 92, 5062-5066. doi: 10.1073/pnas.92.11.5062.
4. Auyeung, B., Lombardo, M. V., and Baron-Cohen, S. (2013). Prenatal and postnatal hormone effects on the human brain and cognition. Pflugers Arch. 465, 557-571. doi: 10.1007/s00424-013-1268-2.
5. Bals-Kubik, R., Herz, A., and Shippenberg, T. S. (1989). Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology (Berl). 98, 203-206. doi: 10.1007/BF00444692.
6. Balthazart, J., and Ball, G. F. (2006). Is brain estradiol a hormone or a neurotransmitter? Trends Neurosci. 29, 241-249. doi: 10.1016/j.tins.2006.03.004.
7. Barrett, A. C., Cook, C. D., Terner, J. M., Roach, E. L., Syvanthong, C., and Picker, M. J. (2002). Sex and rat strain determine sensitivity to kappa opioid-induced antinociception. Psychopharmacology (Berl). 160, 170-181. doi: 10.1007/s00213-001-0949-2.
8. Bastiaens, M. T., ter Huurne, J. A., Kielich, C., Gruis, N. A., Westendorp, R. G., Vermeer, B. J., et al. (2001). Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am. J. Hum. Genet. 68, 884-894. doi: 10.1086/319500.
9. Beardsley, P. M., Howard, J. L., Shelton, K. L., and Carroll, F. I. (2005). Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl). 183, 118-126. doi: 10.1007/s00213-005-0167-4.
10. Beato, M. (1989). Gene regulation by steroid hormones. Cell 56, 335-344. doi: 10.1016/0092-8674(89)90237-7.
11. Becker, J. B., Arnold, A. P., Berkley, K. J., Blaustein, J. D., Eckel, L. A., Hampson, E., et al. (2005). Strategies and methods for research on sex differences in brain and behavior. Endocrinology 146, 1650-1673. doi: 10.1210/en.2004-1142.
12. Becker, J. B., Perry, A. N., and Westenbroek, C. (2012). Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol. Sex Differ. 3:14. doi: 10.1186/2042-6410-3-14.
13. Belknap, J. K., Lamé, M., and Danielson, P. W. (1990). Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassessment. Behav. Genet. 20, 333-338. doi: 10.1007/BF01067800.
14. Berkley, K. J. (1997). Sex differences in pain. Behav. Brain Sci. 20, 371-380; discussion: 435-513. doi: 10.1017/S0140525X97221485.
15. Besse, D., Lombard, M. C., Zajac, J. M., Roques, B. P., and Besson, J. M. (1990). Pre-and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res. 521, 15-22. doi: 10.1016/0006-8993(90)91519-M.
16. Bodkin, J. A., Zornberg, G. L., Lukas, S. E., and Cole, J. O. (1995). Buprenorphine treatment of refractory depression. J. Clin. Psychopharmacol. 15, 49-57. doi: 10.1097/00004714-199502000-00008.
17. Bodnar, R. J., and Kest, B. (2010). Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: central mechanisms of action and roles of gonadal hormones. Horm. Behav. 58, 72-81. doi: 10.1016/j.yhbeh.2009.09.012.
18. Botticelli, L. J., Cox, B. M., and Goldstein, A. (1981). Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proc. Natl. Acad. Sci. U.S.A. 78, 7783-7786. doi: 10.1073/pnas.78.12.7783.
19. Boulware, M. I., Weick, J. P., Becklund, B. R., Kuo, S. P., Groth, R. D., and Mermelstein, P. G. (2005). Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J. Neurosci. 25, 5066-5078. doi: 10.1523/JNEUROSCI.1427-05.2005.
20. Bruchas, M. R., and Chavkin, C. (2010). Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl). 210, 137-147. doi: 10.1007/s00213-010-1806-y.
21. Bruchas, M. R., Land, B. B., and Chavkin, C. (2010). The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 1314, 44-55. doi: 10.1016/j.brainres.2009.08.062.
22. Bruchas, M. R., Xu, M., and Chavkin, C. (2008). Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2. Neuroreport 19, 1417-1422. doi: 10.1097/WNR.0b013e32830dd655.
23. Cahill, C. M., Taylor, A. M., Cook, C., Ong, E., Morón, J. A., and Evans, C. J. (2014). Does the kappa opioid receptor system contribute to pain aversion? Front. Pharmacol. 5:253. doi: 10.3389/fphar.2014.00253.
24. Carey, A. N., Borozny, K., Aldrich, J. V., and McLaughlin, J. P. (2007). Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. Eur. J. Pharmacol. 569, 84-89. doi: 10.1016/j.ejphar.2007.05.007.
25. Carlezon, W. A. Jr. Béguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., et al. (2006). Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J. Pharmacol. Exp. Ther. 316, 440-447. doi: 10.1124/jpet.105.092304.
26. Carlezon, W. A. Jr., and Chartoff, E. H. (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat. Protoc. 2, 2987-2995. doi: 10.1038/nprot.2007.441.
27. Carlezon, W. A. J., Bèguin, C., Knoll, A. T., and Cohen, B. M. (2009). Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol. Ther. 123, 334-343. doi: 10.1016/j.pharmthera.2009.05.008.
28. Carroll, M. E., Lynch, W. J., Roth, M. E., Morgan, A. D., and Cosgrove, K. P. (2004). Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 25, 273-279. doi: 10.1016/j.tips.2004.03.011.
29. Caruso, V., Lagerström, M. C., Olszewski, P. K., Fredriksson, R., and Schiöth, H. B. (2014). Synaptic changes induced by melanocortin signalling. Nat. Rev. Neurosci. 15, 98-110. doi: 10.1038/nrn3657.
30. Chakrabarti, S., Liu, N. J., and Gintzler, A. R. (2010). Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia. Proc. Natl. Acad. Sci. U.S.A. 107, 20115-20119. doi: 10.1073/pnas.1009923107.
31. Chappell, P. B., Leckman, J. F., Scahill, L. D., Hardin, M. T., Anderson, G., and Cohen, D. J. (1993). Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: a pilot study. Psychiatry Res. 47, 267-280. doi: 10.1016/0165-1781(93)90084-T.
32. Chartoff, E., Sawyer, A., Rachlin, A., Potter, D., Pliakas, A., and Carlezon, W. A. (2012). Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology 62, 167-176. doi: 10.1016/j.neuropharm.2011.06.014.
33. Chartoff, E. H., Ebner, S. R., Sparrow, A., Potter, D., Baker, P. M., Ragozzino, M. E., et al. (2015). Relative timing between kappa opioid receptor activation and cocaine determines the impact on reward and dopamine release. Neuropsychopharmacology. doi: 10.1038/npp.2015.226. [Epub ahead of print].
34. Chartoff, E. H., Potter, D., Damez-Werno, D., Cohen, B. M., and Carlezon, W. A. Jr. (2008). Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology 33, 2676-2687. doi: 10.1038/sj.npp.1301659.
35. Chavkin, C. (2013). Dynorphin-still an extraordinarily potent opioid peptide. Mol. Pharmacol. 83, 729-736. doi: 10.1124/mol.112.083337.
36. Chavkin, C., Bakhit, C., and Bloom, F. E. (1983). Evidence for dynorphin-A as a neurotransmitter in rat hippocampus. Life Sci. 33(Suppl. 1), 13-16. doi: 10.1016/0024-3205(83)90432-0.
37. Chavkin, C., and Goldstein, A. (1981). Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc. Natl. Acad. Sci. U.S.A. 78, 6543-6547. doi: 10.1073/pnas.78.10.6543.
38. Chavkin, C., James, I. F., and Goldstein, A. (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215, 413-415. doi: 10.1126/science.6120570.
39. Chen, J., Zhang, R., Chen, X., Wang, C., Cai, X., Liu, H., et al. (2015). Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gas-mediated mechanism. Cell. Signal. 27, 1426-1438. doi: 10.1016/j.cellsig.2015.03.027.
40. Chen, X., Grisham, W., and Arnold, A. P. (2009). X chromosome number causes sex differences in gene expression in adult mouse striatum. Eur. J. Neurosci. 29, 768-776. doi: 10.1111/j.1460-9568.2009.06610.x.
41. Clarke, T. K., Ambrose-Lanci, L., Ferraro, T. N., Berrettini, W. H., Kampman, K. M., Dackis, C. A., et al. (2012). Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes Brain Behav. 11, 415-423. doi: 10.1111/j.1601-183X.2012.00785.x.
42. Clarke, T. K., Krause, K., Li, T., and Schumann, G. (2009). An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Addict. Biol. 14, 366-370. doi: 10.1111/j.1369-1600.2009.00151.x.
43. Cogan, R., and Spinnato, J. A. (1986). Pain and discomfort thresholds in late pregnancy. Pain 27, 63-68. doi: 10.1016/0304-3959(86)90223-X.
44. Cohen, B. M., and Murphy, B. (2008). The effects of pentazocine, a kappa agonist, in patients with mania. Int. J. Neuropsychopharmacol. 11, 243-247. doi: 10.1017/S1461145707008073.
45. Cole, R. L., Konradi, C., Douglass, J., and Hyman, S. E. (1995). Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14, 813-823. doi: 10.1016/0896-6273(95)90225-2.
46. Collaer, M. L., and Hines, M. (1995). Human behavioral sex differences: a role for gonadal hormones during early development? Psychol. Bull. 118, 55-107. doi: 10.1037/0033-2909.118.1.55.
47. Cowan, A. (2003). Buprenorphine: new pharmacological aspects. Int. J. Clin. Pract. 133, 3-8; discussion: 23-24.
48. Craft, R. M., and Bernal, S. A. (2001). Sex differences in opioid antinociception: kappa and 'mixed action' agonists. Drug Alcohol Depend. 63, 215-228. doi: 10.1016/S0376-8716(00)00209-X.
49. Craft, R. M., Kruzich, P. J., Boyer, J. S., Harding, J. W., and Hanesworth, J. M. (1998). Sex differences in discriminative stimulus and diuretic effects of the kappa opioid agonist U69,593 in the rat. Pharmacol. Biochem. Behav. 61, 395-403. doi: 10.1016/S0091-3057(98)00124-5.
50. Crowley, N. A., and Kash, T. L. (2015). Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 62, 51-60. doi: 10.1016/j.pnpbp.2015.01.001.
51. Dawson-Basoa, M., and Gintzler, A. R. (1998). Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems. Brain Res. 794, 61-67. doi: 10.1016/S0006-8993(98)00192-9.
52. de Curtis, M., and Paré, D. (2004). The rhinal cortices: a wall of inhibition between the neocortex and the hippocampus. Prog. Neurobiol. 74, 101-110. doi: 10.1016/j.pneurobio.2004.08.005.
53. Dewing, P., Chiang, C. W., Sinchak, K., Sim, H., Fernagut, P. O., Kelly, S., et al. (2006). Direct regulation of adult brain function by the male-specific factor SRY. Curr. Biol. 16, 415-420. doi: 10.1016/j.cub.2006.01.017.
54. Donzanti, B. A., Althaus, J. S., Payson, M. M., and Von Voigtlander, P. F. (1992). Kappa Agonist-Induced Reduction in Dopamine Release-Site of Action and Tolerance. Res. Commun. Chem. Pathol. Pharmacol. 78, 193-210.
55. Douglass, J., McKinzie, A. A., and Pollock, K. M. (1994). Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol. Endocrinol. 8, 333-344.
56. Douglass, J., McMurray, C. T., Garrett, J. E., Adelman, J. P., and Calavetta, L. (1989). Characterization of the rat prodynorphin gene. Mol. Endocrinol. 3, 2070-2078. doi: 10.1210/mend-3-12-2070.
57. Drake, C. T., Terman, G. W., Simmons, M. L., Milner, T. A., Kunkel, D. D., Schwartzkroin, P. A., et al. (1994). Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J. Neurosci. 14, 3736-3750.
58. Ebner, S. R., Roitman, M. F., Potter, D. N., Rachlin, A. B., and Chartoff, E. H. (2010). Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology (Berl). 210, 241-252. doi: 10.1007/s00213-010-1836-5.
59. Ehrich, E., Turncliff, R., Du, Y., Leigh-Pemberton, R., Fernandez, E., Jones, R., et al. (2015). Evaluation of opioid modulation in major depressive disorder. Neuropsychopharmacology 40, 1448-1455. doi: 10.1038/npp.2014.330.
60. Ehrich, J. M., Phillips, P. E., and Chavkin, C. (2014). Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens. Neuropsychopharmacology 39, 3036-3048. doi: 10.1038/npp.2014.157.
61. Elkabes, S., and Nicot, A. B. (2014). Sex steroids and neuroprotection in spinal cord injury: a review of preclinical investigations. Exp. Neurol. 259, 28-37. doi: 10.1016/j.expneurol.2014.01.008.
62. Emrich, H. M., Vogt, P., and Herz, A. (1982). Possible antidepressive effects of opioids: action of buprenorphine. Ann. N.Y. Acad. Sci. 398, 108-112. doi: 10.1111/j.1749-6632.1982.tb39483.x.
63. Feng, Y., Weijdegård, B., Wang, T., Egecioglu, E., Fernandez-Rodriguez, J., Huhtaniemi, I., et al. (2010). Spatiotemporal expression of androgen receptors in the female rat brain during the oestrous cycle and the impact of exogenous androgen administration: a comparison with gonadally intact males. Mol. Cell. Endocrinol. 321, 161-174. doi: 10.1016/j.mce.2010.02.029.
64. Fillingim, R. B. (2000). Sex, gender, and pain: women and men really are different. Curr. Rev. Pain 4, 24-30. doi: 10.1007/s11916-000-0006-6.
65. Fillingim, R. B., Ness, T. J., Glover, T. L., Campbell, C. M., Price, D. D., and Staud, R. (2004). Experimental pain models reveal no sex differences in pentazocine analgesia in humans. Anesthesiology 100, 1263-1270. doi: 10.1097/00000542-200405000-00031.
66. Ford, C. P., Mark, G. P., and Williams, J. T. (2006). Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J. Neurosci. 26, 2788-2797. doi: 10.1523/JNEUROSCI.4331-05.2006.
67. Forman, L. J., Tingle, V., Estilow, S., and Cater, J. (1989). The response to analgesia testing is affected by gonadal steroids in the rat. Life Sci. 45, 447-454. doi: 10.1016/0024-3205(89)90631-0.
68. Fox, H. C., and Sinha, R. (2009). Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women. Harv. Rev. Psychiatry 17, 103-119. doi: 10.1080/10673220902899680.
69. Fraser, H. F., and Rosenberg, D. E. (1964). Studies on the human addiction liability of 2'-Hydroxy-5-9-Dimethyl-2-(3,3-Dimethylallyl)-6,7-Benzomorphan (Win 20,228): a weak narcotic antagonist. J. Pharmacol. Exp. Ther. 143, 149-156.
70. Fuentealba, J. A., Gysling, K., and Andrés, M. E. (2007). Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593. Synapse 61, 771-777. doi: 10.1002/syn.20424.
71. Fuentealba, J. A., Gysling, K., Magendzo, K., and Andrés, M. E. (2006). Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens. J. Neurosci. Res. 84, 450-459. doi: 10.1002/jnr.20890.
72. Gear, R. W., Gordon, N. C., Heller, P. H., Paul, S., Miaskowski, C., and Levine, J. D. (1996). Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci. Lett. 205, 207-209. doi: 10.1016/0304-3940(96)12402-2.
73. Gear, R. W., Miaskowski, C., Gordon, N. C., Paul, S. M., Heller, P. H., and Levine, J. D. (1999). The kappa opioid nalbuphine produces gender-and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain 83, 339-345. doi: 10.1016/S0304-3959(99)00119-0.
74. Gerra, G., Fantoma, A., and Zaimovic, A. (2006). Naltrexone and buprenorphine combination in the treatment of opioid dependence. J. Psychopharmacol. (Oxford). 20, 806-814. doi: 10.1177/0269881106060835.
75. Gintzler, A. R., and Liu, N. J. (2012). Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors. Front. Neuroendocrinol. 33, 412-424. doi: 10.1016/j.yfrne.2012.09.004.
76. Gintzler, A. R., Schnell, S. A., Gupta, D. S., Liu, N. J., and Wessendorf, M. W. (2008). Relationship of spinal dynorphin neurons to delta-opioid receptors and estrogen receptor alpha: anatomical basis for ovarian sex steroid opioid antinociception. J. Pharmacol. Exp. Ther. 326, 725-731. doi: 10.1124/jpet.108.139816.
77. Gonzalez, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., and Barbanoj, M. J. (2006). Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend. 85, 157-162. doi: 10.1016/j.drugalcdep.2006.04.001.
78. Goodfellow, P. N., and Lovell-Badge, R. (1993). SRY and sex determination in mammals. Annu. Rev. Genet. 27, 71-92. doi: 10.1146/annurev.ge.27.120193.000443.
79. Gottsch, M. L., Navarro, V. M., Zhao, Z., Glidewell-Kenney, C., Weiss, J., Jameson, J. L., et al. (2009). Regulation of Kiss1 and dynorphin gene expression in the murine brain by classical and nonclassical estrogen receptor pathways. J. Neurosci. 29, 9390-9395. doi: 10.1523/JNEUROSCI.0763-09.2009.
80. Gouardères, C., Kopp, N., Cros, J., and Quirion, R. (1986). Kappa opioid receptors in human lumbo-sacral spinal cord. Brain Res. Bull. 16, 355-361. doi: 10.1016/0361-9230(86)90056-0.
81. Graziane, N. M., Polter, A. M., Briand, L. A., Pierce, R. C., and Kauer, J. A. (2013). Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron 77, 942-954. doi: 10.1016/j.neuron.2012.12.034.
82. Greenfield, S. F., Back, S. E., Lawson, K., and Brady, K. T. (2010). Substance abuse in women. Psychiatr. Clin. North Am. 33, 339-355. doi: 10.1016/j.psc.2010.01.004.
83. Griffin, M. L., Weiss, R. D., Mirin, S. M., and Lange, U. (1989). A Comparison of Male and Female Cocaine Abusers. Arch. Gen. Psychiatry 46, 122-126. doi: 10.1001/archpsyc.1989.01810020024005.
84. Gruber, C. J., Gruber, D. M., Gruber, I. M., Wieser, F., and Huber, J. C. (2004). Anatomy of the estrogen response element. Trends Endocrinol. Metab. 15, 73-78. doi: 10.1016/j.tem.2004.01.008.
85. Grudt, T. J., and Williams, J. T. (1995). Opioid receptors and the regulation of ion conductances. Rev. Neurosci. 6, 279-286. doi: 10.1515/REVNEURO.1995.6.3.279.
86. Gu, G., Rojo, A. A., Zee, M. C., Yu, J., and Simerly, R. B. (1996). Hormonal regulation of CREB phosphorylation in the anteroventral periventricular nucleus. J. Neurosci. 16, 3035-3044.
87. Gupta, D. S., Kelson, A. B., Polgar, W. E., Toll, L., Szücs, M., and Gintzler, A. R. (2001). Ovarian sex steroid-dependent plasticity of nociceptin/orphanin FQ and opioid modulation of spinal dynorphin release. J. Pharmacol. Exp. Ther. 298, 1213-1220.
88. Hamson, D. K., Jones, B. A., and Watson, N. V. (2004). Distribution of androgen receptor immunoreactivity in the brainstem of male rats. Neuroscience 127, 797-803. doi: 10.1016/j.neuroscience.2004.06.006.
89. Han, J. S., and Xie, C. W. (1982). Dynorphin: potent analgesic effect in spinal cord of the rat. Life Sci. 31, 1781-1784. doi: 10.1016/0024-3205(82)90209-0.
90. Han, J. S., and Xie, C. W. (1984). Dynorphin: potent analgesic effect in spinal cord of the rat. Sci. Sin. B 27, 169-177.
91. Hanes, K. R. (2001). Antidepressant effects of the herb Salvia divinorum: a case report. J. Clin. Psychopharmacol. 21, 634-635. doi: 10.1097/00004714-200112000-00025.
92. Harris, J. A., Chang, P. C., and Drake, C. T. (2004). Kappa opioid receptors in rat spinal cord: sex-linked distribution differences. Neuroscience 124, 879-890. doi: 10.1016/j.neuroscience.2003.12.042.
93. Heidbreder, C. A., Babovic-Vuksanovic, D., Shoaib, M., and Shippenberg, T. S. (1995). Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists. J. Pharmacol. Exp. Ther. 275, 150-163.
94. Heidbreder, C. A., Schenk, S., Partridge, B., and Shippenberg, T. S. (1998). Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse 30, 255-262.
95. Horikawa, S., Takai, T., Toyosato, M., Takahashi, H., Noda, M., Kakidani, H., et al. (1983). Isolation and structural organization of the human preproenkephalin B gene. Nature 306, 611-614. doi: 10.1038/306611a0.
96. Hurd, Y. L., and Herkenham, M. (1993). Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13, 357-369. doi: 10.1002/syn.890130408.
97. Iadarola, M. J., Brady, L. S., Draisci, G., and Dubner, R. (1988). Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35, 313-326. doi: 10.1016/0304-3959(88)90141-8.
98. Ji, R. R., Zhang, Q., Law, P. Y., Low, H. H., Elde, R., and Hökfelt, T. (1995). Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J. Neurosci. 15, 8156-8166.
99. Karp, J. F., Butters, M. A., Begley, A. E., Miller, M. D., Lenze, E. J., Blumberger, D. M., et al. (2014). Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults. J. Clin. Psychiatry 75, e785-e793. doi: 10.4088/JCP.13m08725.
100. Kavaliers, M., and Choleris, E. (1997). Sex differences in N-methyl-D-aspartate involvement in kappa opioid and non-opioid predator-induced analgesia in mice. Brain Res. 768, 30-36. doi: 10.1016/S0006-8993(97)00569-6.
101. Kavaliers, M., and Galea, L. A. (1995). Sex differences in the expression and antagonism of swim stress-induced analgesia in deer mice vary with the breeding season. Pain 63, 327-334. doi: 10.1016/0304-3959(95)00063-1.
102. Kavaliers, M., and Innes, D. G. (1987). Sex and day-night differences in opiate-induced responses of insular wild deer mice, Peromyscus maniculatus triangularis. Pharmacol. Biochem. Behav. 27, 477-482. doi: 10.1016/0091-3057(87)90351-0.
103. Kelsey, J. E., Verhaak, A. M., and Schierberl, K. C. (2015). The kappa opioid receptor antagonist, nor-binaltorphimine (nor-BNI) decreases morphine withdrawal and the consequent conditioned place aversions in rats. Behav. Br. Res. 283, 16-21. doi: 10.1016/j.bbr.2015.01.008.
104. Kenny, P. J. (2007). Brain reward systems and compulsive drug use. Trends Pharmacol. Sci. 28, 135-141. doi: 10.1016/j.tips.2007.01.008.
105. Kern, A., Albarran-Zeckler, R., Walsh, H. E., and Smith, R. G. (2012). Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73, 317-332. doi: 10.1016/j.neuron.2011.10.038.
106. Kessler, R. C. (2003). Epidemiology of women and depression. J. Affect. Disord. 74, 5-13. doi: 10.1016/S0165-0327(02)00426-3.
107. Klinge, C. M., Jernigan, S. C., Mattingly, K. A., Risinger, K. E., and Zhang, J. (2004). Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J. Mol. Endocrinol. 33, 387-410. doi: 10.1677/jme.1.01541.
108. Knoll, A. T., and Carlezon, W. A. Jr. (2010). Dynorphin, stress, and depression. Brain Res. 1314, 56-73. doi: 10.1016/j.brainres.2009.09.074.
109. Knoll, A. T., Meloni, E. G., Thomas, J. B., Carroll, F. I., and Carlezon, W. A. Jr. (2007). Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J. Pharmacol. Exp. Ther. 323, 838-845. doi: 10.1124/jpet.107.127415.
110. Knoll, A. T., Muschamp, J. W., Sillivan, S. E., Ferguson, D., Dietz, D. M., Meloni, E. G., et al. (2011). Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol. Psychiatry 70, 425-433. doi: 10.1016/j.biopsych.2011.03.017.
111. Koob, G. F. (2008). A role for brain stress systems in addiction. Neuron 59, 11-34. doi: 10.1016/j.neuron.2008.06.012.
112. Koob, G. F., and Le Moal, M. (2008). Addiction and the brain antireward system. Annu. Rev. Psychol. 59, 29-53. doi: 10.1146/annurev.psych.59.103006.093548.
113. Kosten, T. R., Morgan, C., and Kosten, T. A. (1990). Depressive symptoms during buprenorphine treatment of opioid abusers. J. Subst. Abuse Treat. 7, 51-54. doi: 10.1016/0740-5472(90)90035-O.
114. Laflamme, N., Nappi, R. E., Drolet, G., Labrie, C., and Rivest, S. (1998). Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 36, 357-378.
115. Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., and Chavkin, C. (2008). The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system. J. Neurosci. 28, 407-414. doi: 10.1523/JNEUROSCI.4458-07.2008.
116. Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., et al. (2009). Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc. Natl. Acad. Sci. U.S.A. 106, 19168-19173. doi: 10.1073/pnas.0910705106.
117. Lander, E. S., and Schork, N. J. (1994). Genetic dissection of complex traits. Science 265, 2037-2048. doi: 10.1126/science.8091226.
118. Law, P. Y., Wong, Y. H., and Loh, H. H. (2000). Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40, 389-430. doi: 10.1146/annurev.pharmtox.40.1.389.
119. Lawson, K. P., Nag, S., Thompson, A. D., and Mokha, S. S. (2010). Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia. Pain 151, 806-815. doi: 10.1016/j.pain.2010.09.018.
120. Le Merrer, J., Becker, J. A., Befort, K., and Kieffer, B. L. (2009). Reward processing by the opioid system in the brain. Physiol. Rev. 89, 1379-1412. doi: 10.1152/physrev.00005.2009.
121. Limonta, P., Dondi, D., Maggi, R., Martini, L., and Piva, F. (1989). Neonatal organization of the brain opioid systems controlling prolactin and luteinizing hormone secretion. Endocrinology 124, 681-686. doi: 10.1210/endo-124-2-681.
122. Liu, N. J., Chakrabarti, S., Schnell, S., Wessendorf, M., and Gintzler, A. R. (2011). Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal kappa-and mu-opioid receptor heterodimerization and female-specific spinal morphine antinociception. J. Neurosci. 31, 11836-11845. doi: 10.1523/JNEUROSCI.1901-11.2011.
123. Liu-Chen, L. Y. (2004). Agonist-induced regulation and trafficking of kappa opioid receptors. Life Sci. 75, 511-536. doi: 10.1016/j.lfs.2003.10.041.
124. Lohse, M. J. (2010). Dimerization in GPCR mobility and signaling. Curr. Opin. Pharmacol. 10, 53-58. doi: 10.1016/j.coph.2009.10.007.
125. Loyd, D. R., and Murphy, A. Z. (2008). Androgen and estrogen (alpha) receptor localization on periaqueductal gray neurons projecting to the rostral ventromedial medulla in the male and female rat. J. Chem. Neuroanat. 36, 216-226. doi: 10.1016/j.jchemneu.2008.08.001.
126. Lumbroso, S., Sandillon, F., Georget, V., Lobaccaro, J. M., Brinkmann, A. O., Privat, A., et al. (1996). Immunohistochemical localization and immunoblotting of androgen receptor in spinal neurons of male and female rats. Eur. J. Endocrinol. 134, 626-632. doi: 10.1530/eje.0.1340626.
127. Lynch, W. J. (2006). Sex differences in vulnerability to drug self-administration. Exp. Clin. Psychopharmacol. 14, 34-41. doi: 10.1037/1064-1297.14.1.34.
128. Lynch, W. J., and Taylor, J. R. (2004). Sex differences in the behavioral effects of 24-h/day access to cocaine under a discrete trial procedure. Neuropsychopharmacology 29, 943-951. doi: 10.1038/sj.npp.1300389.
129. Maekawa, K., Minami, M., Yabuuchi, K., Toya, T., Katao, Y., Hosoi, Y., et al. (1994). In situ hybridization study of mu-and kappa-opioid receptor mRNAs in the rat spinal cord and dorsal root ganglia. Neurosci. Lett. 168, 97-100. doi: 10.1016/0304-3940(94)90425-1.
130. Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C. Jr., et al. (2003). Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 305, 323-330. doi: 10.1124/jpet.102.046433.
131. Mansour, A., Burke, S., Pavlic, R. J., Akil, H., and Watson, S. J. (1996). Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 71, 671-690. doi: 10.1016/0306-4522(95)00464-5.
132. Mansour, A., Fox, C. A., Akil, H., and Watson, S. J. (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29. doi: 10.1016/0166-2236(95)93946-U.
133. Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., et al. (1994a). Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350, 412-438. doi: 10.1002/cne.903500307.
134. Mansour, A., Fox, C. A., Meng, F., Akil, H., and Watson, S. J. (1994b). Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol. Cell. Neurosci. 5, 124-144. doi: 10.1006/mcne.1994.1015.
135. Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H., and Watson, S. J. (1988). Anatomy of CNS opioid receptors. Trends Neurosci. 11, 308-314. doi: 10.1016/0166-2236(88)90093-8.
136. Marchant, N. J., Densmore, V. S., and Osborne, P. B. (2007). Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J. Comp. Neurol. 504, 702-715. doi: 10.1002/cne.21464.
137. Margolis, E. B., Hjelmstad, G. O., Bonci, A., and Fields, H. L. (2003). Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J. Neurosci. 23, 9981-9986.
138. Margolis, E. B., Hjelmstad, G. O., Bonci, A., and Fields, H. L. (2005). Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. J. Neurophysiol. 93, 3086-3093. doi: 10.1152/jn.00855.2004.
139. Margolis, E. B., Lock, H., Chefer, V. I., Shippenberg, T. S., Hjelmstad, G. O., and Fields, H. L. (2006). Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 103, 2938-2942. doi: 10.1073/pnas.0511159103.
140. Marinelli, S., Vaughan, C. W., Schnell, S. A., Wessendorf, M. W., and Christie, M. J. (2002). Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J. Neurosci. 22, 10847-10855.
141. McCarthy, M. M. (2010). How it's made: organisational effects of hormones on the developing brain. J. Neuroendocrinol. 22, 736-742. doi: 10.1111/j.1365-2826.2010.02021.x.
142. McCarthy, M. M., and Arnold, A. P. (2011). Reframing sexual differentiation of the brain. Nat. Neurosci. 14, 677-683. doi: 10.1038/nn.2834.
143. McCarthy, M. M., Arnold, A. P., Ball, G. F., Blaustein, J. D., and De Vries, G. J. (2012). Sex differences in the brain: the not so inconvenient truth. J. Neurosci. 32, 2241-2247. doi: 10.1523/JNEUROSCI.5372-11.2012.
144. McKay, J. R., Rutherford, M. J., Cacciola, J. S., Kabasakalian-McKay, R., and Alterman, A. I. (1996). Gender differences in the relapse experiences of cocaine patients. J. Nerv. Ment. Dis. 184, 616-622. doi: 10.1097/00005053-199610000-00006.
145. McLaughlin, J. P., Land, B. B., Li, S., Pintar, J. E., and Chavkin, C. (2006). Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31, 787-794. doi: 10.1038/sj.npp.1300860.
146. Millan, M. J., Czlonkowski, A., Lipkowski, A., and Herz, A. (1989). Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. J. Pharmacol. Exp. Ther. 251, 342-350.
147. Mogil, J. S., and Bailey, A. L. (2010). Sex and gender differences in pain and analgesia. Prog. Brain Res. 186, 141-157. doi: 10.1016/b978-0-444-53630-3.00009-9.
148. Mogil, J. S., and Belknap, J. K. (1997). Sex and genotype determine the selective activation of neurochemically-distinct mechanisms of swim stress-induced analgesia. Pharmacol. Biochem. Behav. 56, 61-66. doi: 10.1016/S0091-3057(96)00157-8.
149. Mogil, J. S., Chesler, E. J., Wilson, S. G., Juraska, J. M., and Sternberg, W. F. (2000). Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci. Biobehav. Rev. 24, 375-389. doi: 10.1016/S0149-7634(00)00015-4.
150. Mogil, J. S., Sternberg, W. F., Kest, B., Marek, P., and Liebeskind, J. C. (1993). Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain 53, 17-25. doi: 10.1016/0304-3959(93)90050-Y.
151. Mogil, J. S., Wilson, S. G., Chesler, E. J., Rankin, A. L., Nemmani, K. V., Lariviere, W. R., et al. (2003). The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 100, 4867-4872. doi: 10.1073/pnas.0730053100.
152. Morris, B. J., and Herz, A. (1987). Distinct distribution of opioid receptor types in rat lumbar spinal cord. Naunyn Schmiedebergs. Arch. Pharmacol. 336, 240-243. doi: 10.1007/BF00165811.
153. Mostari, P., Ieda, N., Deura, C., Minabe, S., Yamada, S., Uenoyama, Y., et al. (2013). dynorphin-kappa opioid receptor signaling partly mediates estrogen negative feedback effect on LH pulses in female rats. J. Reprod. Dev. 59, 266-272. doi: 10.1262/jrd.2012-193.
154. Mu, P., Neumann, P. A., Panksepp, J., Schlüter, O. M., and Dong, Y. (2011). Exposure to cocaine alters dynorphin-mediated regulation of excitatory synaptic transmission in nucleus accumbens neurons. Biol. Psychiatry 69, 228-235. doi: 10.1016/j.biopsych.2010.09.014.
155. Muschamp, J. W., Hollander, J. A., Thompson, J. L., Voren, G., Hassinger, L. C., Onvani, S., et al. (2014). Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc. Natl. Acad. Sci. U.S.A. 111, E1648-E1655. doi: 10.1073/pnas.1315542111.
156. Muschamp, J. W., Van't Veer, A., Parsegian, A., Gallo, M. S., Chen, M., Neve, R. L., et al. (2011). Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats. J. Neurosci. 31, 3095-3103. doi: 10.1523/JNEUROSCI.5973-10.2011.
157. Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., et al. (2006). Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31, 739-750. doi: 10.1038/sj.npp.1300858.
158. Negus, S. S. (2004). Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology (Berl). 176, 204-213. doi: 10.1007/s00213-004-1878-7.
159. Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., et al. (2002). Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22, 10883-10890.
160. Nyhuis, P. W., Gastpar, M., and Scherbaum, N. (2008). Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy. J. Clin. Psychopharmacol. 28, 593-595. doi: 10.1097/JCP.0b013e31818638a4.
161. Papka, R. E., Storey-Workley, M., Shughrue, P. J., Merchenthaler, I., Collins, J. J., Usip, S., et al. (2001). Estrogen receptor-alpha and beta-immunoreactivity and mRNA in neurons of sensory and autonomic ganglia and spinal cord. Cell Tissue Res. 304, 193-214. doi: 10.1007/s004410100363.
162. Peckys, D., and Landwehrmeyer, G. B. (1999). Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience 88, 1093-1135. doi: 10.1016/S0306-4522(98)00251-6.
163. Pfeiffer, A., Brantl, V., Herz, A., and Emrich, H. M. (1986). Psychotomimesis mediated by kappa opiate receptors. Science 233, 774-776. doi: 10.1126/science.3016896.
164. Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., and Carlezon, W. A. Jr. (2001). Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21, 7397-7403.
165. Potter, D. N., Damez-Werno, D., Carlezon, W. A. Jr. Cohen, B. M., and Chartoff, E. H. (2011). Repeated exposure to the kappa-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biol. Psychiatry 70, 744-753. doi: 10.1016/j.biopsych.2011.05.021.
166. Prinster, S. C., Hague, C., and Hall, R. A. (2005). Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57, 289-298. doi: 10.1124/pr.57.3.1.
167. Randic, M., Cheng, G., and Kojic, L. (1995). kappa-opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord. J. Neurosci. 15, 6809-6826.
168. Rasakham, K., and Liu-Chen, L. Y. (2011). Sex differences in kappa opioid pharmacology. Life Sci. 88, 2-16. doi: 10.1016/j.lfs.2010.10.007.
169. Redila, V., and Chavkin, C. (2008). Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl). 200, 59-70. doi: 10.1007/s00213-008-1122-y.
170. Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., and Prossnitz, E. R. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630. doi: 10.1126/science.1106943.
171. Riley, J. L. III, Robinson, M. E., Wise, E. A., Myers, C. D., and Fillingim, R. B. (1998). Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain 74, 181-187. doi: 10.1016/S0304-3959(97)00199-1.
172. Robles, C. F., McMackin, M. Z., Campi, K. L., Doig, I. E., Takahashi, E. Y., Pride, M. C., et al. (2014). Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females. Behav. Brain Res. 262, 84-93. doi: 10.1016/j.bbr.2014.01.003.
173. Rothman, R. B., Gorelick, D. A., Heishman, S. J., Eichmiller, P. R., Hill, B. H., Norbeck, J., et al. (2000). An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence. J. Subst. Abuse Treat. 18, 277-281. doi: 10.1016/S0740-5472(99)00074-4.
174. Russell, S. E., Rachlin, A. B., Smith, K. L., Muschamp, J., Berry, L., Zhao, Z., et al. (2014). Sex Differences in Sensitivity to the Depressive-like Effects of the Kappa Opioid Receptor Agonist U-50488 in Rats. Biol. Psychiatry 76, 213-222. doi: 10.1016/j.biopsych.2013.07.042.
175. Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., Marth, G., et al. (2001). A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928-933. doi: 10.1038/35057149.
176. Schindler, A. G., Li, S., and Chavkin, C. (2010). Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms. Neuropsychopharmacology 35, 1932-1942. doi: 10.1038/npp.2010.67.
177. Scott, C. J., Clarke, I. J., and Tilbrook, A. J. (2008). The effect of testosterone and season on prodynorphin messenger RNA expression in the preoptic area-hypothalamus of the ram. Domest. Anim. Endocrinol. 34, 440-450. doi: 10.1016/j.domaniend.2008.01.001.
178. Sershen, H., Hashim, A., and Lajtha, A. (1998). Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release. Brain Res. 801, 67-71. doi: 10.1016/S0006-8993(98)00546-0.
179. Shippenberg, T. S., and Rea, W. (1997). Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol. Biochem. Behav. 57, 449-455. doi: 10.1016/S0091-3057(96)00450-9.
180. Shippenberg, T. S., Zapata, A., and Chefer, V. I. (2007). Dynorphin and the pathophysiology of drug addiction. Pharmacol. Ther. 116, 306-321. doi: 10.1016/j.pharmthera.2007.06.011.
181. Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1997). Comparative distribution of estrogen receptor-alpha and-beta mRNA in the rat central nervous system. J. Comp. Neurol. 388, 507-525.
182. Shyu, W. C., Morgenthien, E. A., Pittman, K. A., and Barbhaiya, R. H. (1994). The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol. Eur. J. Clin. Pharmacol. 47, 57-60. doi: 10.1007/BF00193479.
183. Sibille, K. T., Kindler, L. L., Glover, T. L., Gonzalez, R. D., Staud, R., Riley, J. L. III, et al. (2011). Individual differences in morphine and butorphanol analgesia: a laboratory pain study. Pain Med. 12, 1076-1085. doi: 10.1111/j.1526-4637.2011.01157.x.
184. Simerly, R. B., Chang, C., Muramatsu, M., and Swanson, L. W. (1990). Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294, 76-95. doi: 10.1002/cne.902940107.
185. Simmons, M. L., and Chavkin, C. (1996). Endogenous opioid regulation of hippocampal function. Int. Rev. Neurobiol. 39, 145-196. doi: 10.1016/S0074-7742(08)60666-2.
186. Simonin, F., Gavériaux-Ruff, C., Befort, K., Matthes, H., Lannes, B., Micheletti, G., et al. (1995). kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 92, 7006-7010. doi: 10.1073/pnas.92.15.7006.
187. Slowe, S. J., Simonin, F., Kieffer, B., and Kitchen, I. (1999). Quantitative autoradiography of mu-, delta-and kappa1 opioid receptors in kappa-opioid receptor knockout mice. Brain Res. 818, 335-345. doi: 10.1016/S0006-8993(98)01201-3.
188. Spanagel, R., Herz, A., and Shippenberg, T. S. (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89, 2046-2050. doi: 10.1073/pnas.89.6.2046.
189. Sternberg, W. F., Chesler, E. J., Wilson, S. G., and Mogil, J. S. (2004a). Acute progesterone can recruit sex-specific neurochemical mechanisms mediating swim stress-induced and kappa-opioid analgesia in mice. Horm. Behav. 46, 467-473. doi: 10.1016/j.yhbeh.2004.05.007.
190. Sternberg, W. F., Ritchie, J., and Mogil, J. S. (2004b). Qualitative sex differences in kappa-opioid analgesia in mice are dependent on age. Neurosci. Lett. 363, 178-181. doi: 10.1016/j.neulet.2004.04.004.
191. Stoffel, E. C., Ulibarri, C. M., Folk, J. E., Rice, K. C., and Craft, R. M. (2005). Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats. J. Pain 6, 261-274. doi: 10.1016/j.jpain.2004.12.006.
192. Sturm, R. A., Teasdale, R. D., and Box, N. F. (2001). Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277, 49-62. doi: 10.1016/S0378-1119(01)00694-1.
193. Substance Abuse Mental Health Services Administration (2014). "Results from the 2013 national survey on drug use and health: summary of national findings," in National Survey on Drug Use and Health Series H-48 (Rockville, MD: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration) Publication No. (SMA) 14-4863.
194. Svingos, A. L., Colago, E. E., and Pickel, V. M. (1999). Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J. Neurosci. 19, 1804-1813.
195. Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., and Carlezon, W. A. Jr. (2004). Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl). 172, 463-470. doi: 10.1007/s00213-003-1680-y.
196. Tomasiewicz, H. C., Todtenkopf, M. S., Chartoff, E. H., Cohen, B. M., and Carlezon, W. A. Jr. (2008). The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward. Biol. Psychiatry 64, 982-988. doi: 10.1016/j.biopsych.2008.05.029.
197. Torres-Reveron, A., Khalid, S., Williams, T. J., Waters, E. M., Jacome, L., Luine, V. N., et al. (2009). Hippocampal dynorphin immunoreactivity increases in response to gonadal steroids and is positioned for direct modulation by ovarian steroid receptors. Neuroscience 159, 204-216. doi: 10.1016/j.neuroscience.2008.12.023.
198. Tsuang, M. T., Lyons, M. J., Eisen, S. A., Goldberg, J., True, W., Lin, N., et al. (1996). Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am. J. Med. Genet. 67, 473-477.
199. Vanderhorst, V. G., Gustafsson, J. A., and Ulfhake, B. (2005). Estrogen receptor-alpha and-beta immunoreactive neurons in the brainstem and spinal cord of male and female mice: relationships to monoaminergic, cholinergic, and spinal projection systems. J. Comp. Neurol. 488, 152-179. doi: 10.1002/cne.20569.
200. Vonvoigtlander, P. F., Lahti, R. A., and Ludens, J. H. (1983). U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224, 7-12.
201. Walker, B. M., and Koob, G. F. (2007). Pharmacological Evidence for a Motivational Role of [kappa]-Opioid Systems in Ethanol Dependence. Neuropsychopharmacology 33, 643-652. doi: 10.1038/sj.npp.1301438.
202. Walker, Q. D., Rooney, M. B., Wightman, R. M., and Kuhn, C. M. (2000). Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience 95, 1061-1070. doi: 10.1016/S0306-4522(99)00500-X.
203. Walsh, S. L., Preston, K. L., Bigelow, G. E., and Stitzer, M. L. (1995). Acute administration of buprenorphine in humans: partial agonist and blockade effects. J. Pharmacol. Exp. Ther. 274, 361-372.
204. Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., and Bigelow, G. E. (1994). Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin. Pharmacol. Ther. 55, 569-580. doi: 10.1038/clpt.1994.71.
205. Wang, D. G., Fan, J. B., Siao, C. J., Berno, A., Young, P., Sapolsky, R., et al. (1998). Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280, 1077-1082. doi: 10.1126/science.280.5366.1077.
206. Wang, Y. J., Rasakham, K., Huang, P., Chudnovskaya, D., Cowan, A., and Liu-Chen, L. Y. (2011). Sex difference in kappa-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig. J. Pharmacol. Exp. Ther. 339, 438-450. doi: 10.1124/jpet.111.183905.
207. Watkins, L. R., Wiertelak, E. P., and Maier, S. F. (1992). Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels. Brain Res. 582, 1-9. doi: 10.1016/0006-8993(92)90310-6.
208. Wee, S., Orio, L., Ghirmai, S., Cashman, J., and Koob, G. (2009). Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology (Berl). 205, 565-575. doi: 10.1007/s00213-009-1563-y.
209. Weissman, M. M., and Olfson, M. (1995). Depression in women: implications for health care research. Science 269, 799-801. doi: 10.1126/science.7638596.
210. Wiesenfeld-Hallin, Z. (2005). Sex differences in pain perception. Gend. Med. 2, 137-145. doi: 10.1016/S1550-8579(05)80042-7.
211. Williams, J. T., Christie, M. J., and Manzoni, O. (2001). Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299-343.
212. Yaksh, T. L. (1997). Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol. Scand. 41, 94-111. doi: 10.1111/j.1399-6576.1997.tb04623.x.
213. Yuferov, V., Ji, F., Nielsen, D. A., Levran, O., Ho, A., Morgello, S., et al. (2009). A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34, 1185-1197. doi: 10.1038/npp.2008.187.
214. Zacny, J. P., and Beckman, N. J. (2004). The effects of a cold-water stimulus on butorphanol effects in males and females. Pharmacol. Biochem. Behav. 78, 653-659. doi: 10.1016/j.pbb.2004.01.021.
215. Zhu, J., Luo, L. Y., Li, J. G., Chen, C., and Liu-Chen, L. Y. (1997). Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. J. Pharmacol. Exp. Ther. 282, 676-684.